Ascendis Pharma AS (ASND)
129.81
+7.17
(+5.85%)
USD |
NASDAQ |
Nov 22, 16:00
134.49
+4.68
(+3.61%)
After-Hours: 20:00
Ascendis Pharma Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 7.772M |
| December 31, 2023 | 5.472M |
| September 30, 2023 | 23.77M |
| June 30, 2023 | 54.66M |
| March 31, 2023 | 226.24M |
| December 31, 2022 | 2.112M |
| September 30, 2022 | 11.40M |
| June 30, 2022 | 8.338M |
| March 31, 2022 | 43.25M |
| December 31, 2021 | -132.42M |
| September 30, 2021 | 24.58M |
| June 30, 2021 | 13.29M |
| March 31, 2021 | -36.29M |
| December 31, 2020 | -75.21M |
| September 30, 2020 | 11.91M |
| June 30, 2020 | -262.48M |
| March 31, 2020 | -6.777M |
| December 31, 2019 | -1.294M |
| September 30, 2019 | -1.358M |
| June 30, 2019 | -0.3184M |
| March 31, 2019 | -2.805M |
| Date | Value |
|---|---|
| December 31, 2018 | -1.282M |
| September 30, 2018 | -1.324M |
| June 30, 2018 | -0.3965M |
| March 31, 2018 | -0.1253M |
| December 31, 2017 | -0.2357M |
| September 30, 2017 | -0.1863M |
| June 30, 2017 | -0.242M |
| March 31, 2017 | -0.4016M |
| December 31, 2016 | -0.1076M |
| September 30, 2016 | -0.173M |
| June 30, 2016 | -0.311M |
| March 31, 2016 | -0.1522M |
| December 31, 2015 | -0.4017M |
| September 30, 2015 | -0.0971M |
| June 30, 2015 | -0.5572M |
| March 31, 2015 | -0.097M |
| December 31, 2014 | -0.0535M |
| September 30, 2014 | -0.0681M |
| June 30, 2014 | -0.2457M |
| March 31, 2014 | -0.1713M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-262.48M
Minimum
Jun 2020
226.24M
Maximum
Mar 2023
-4.537M
Average
8.055M
Median
Cash from Investing (Quarterly) Benchmarks
| Novo Nordisk AS | -3.131B |
| Evaxion Biotech AS | -- |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | -- |
| TC BioPharm (Holdings) PLC | -0.0071M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow Yield | -6.21% |